Molecular Weight: 472.47 g/mol
Chemical Structure
Check the
Darovasertib (LXS196)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
94 mg/mL
(198.95 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 47 mg/mL |
| Water | Insoluble |
| DMSO |
60 mg/mL
(126.99 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 20 mg/mL |
| Water | Insoluble |
| DMSO |
60 mg/mL
(126.99 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 20 mg/mL |
| Water | Insoluble |
| DMSO |
22 mg/mL
(46.56 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 6 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
| IUPAC Name | 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]pyrazine-2-carboxamide | |
|---|---|---|
| CAS Number | 1874276-76-2 | |
| Molecular Formula |
C22H23F3N8O |
|
| Molecular Weight (MW) | 472.47 | |
| SMILES | CC1(CCN(CC1)C2=C(N=CC=C2)NC(=O)C3=NC(=CN=C3N)C4=C(C=CC=N4)C(F)(F)F)N | |
| InChIKey | XXJXHXJWQSCNPX-UHFFFAOYSA-N |
- Darovasertib (LXS196) Mechanism of Action: PKC Inhibition in Melanocyte Research
- Darovasertib (LXS196) Clinical Trials
- Darovasertib (LXS196) Working Concentration | Cell Culture | Treatment
- Darovasertib (LXS196) Solubility in DMSO
- Darovasertib (LXS196) Stock Solution
- Darovasertib (LXS196) Storage
- Darovasertib (LXS196) Stability
- Darovasertib (LXS196) Combination Database
- Darovasertib (LXS196) SMILES
- Darovasertib (LXS196) CAS Number
- Darovasertib (LXS196) Chemical Structure (2D and 3D)
- Darovasertib (LXS196) IC50 for Cell-based and Cell-free Assays
- Darovasertib (LXS196) MedChemExpress (HY-101569)? Try a better option.
- Darovasertib (LXS196) Sigma (AMBH9A2607F4)? Try a better option.
- Darovasertib (LXS196) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.